von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)1 Tập 14 Số 2 - Trang 171-232 - 2008
William L. Nichols, MB Hultin, Allison James, M. J. Manco‐Johnson, Robert R. Montgomery, Thomas L. Ortel, Margaret E. Rick, J. Evan Sadler, Mark Weinstein, Barbara P. Yawn
Summary. von Willebrand disease (VWD) is a commonly encountered inherited bleeding disorder affecting both males and females, causing mucous membrane and skin bleeding symptoms, and bleeding with surgical or other haemostatic challenges. VWD may be disproportionately symptomatic in women of child‐bearing age. It may also occur less frequently as an acquired disorder...... hiện toàn bộ The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation Tập 10 Số 5 - Trang 593-628 - 2004
Paula Bolton‐Maggs, David J. Perry, Elizabeth Chalmers, L. A. Parapia, J Wilde, Michael D. Williams, Peter W. Collins, Steve Kitchen, Gerard Dolan, Andrew Mumford
Summary. The rare coagulation disorders are heritable abnormalities of haemostasis that may present significant difficulties in diagnosis and management. This review summarizes the current literature for disorders of fibrinogen, and deficiencies of prothrombin, factor V, FV + VIII, FVII, FX, the combined vitamin K‐dependent factors, FXI and FXIII. Based on both coll...... hiện toàn bộ Inherited antithrombin deficiency: a review Tập 14 Số 6 - Trang 1229-1239 - 2008
Mrinal M. Patnaik, Stephan Moll
Summary. Antithrombin (AT) is a potent inactivator of thrombin and factor Xa and the major inhibitor of blood coagulation. Inherited AT deficiencies are uncommon, with prevalences in the general population between 1 in 500 and 1 in 5000. They are either quantitative (type I) or qualitative (type II). Type II is subdivided into the more common, but less thrombogenic,...... hiện toàn bộ Rare coagulation deficiencies Tập 8 Số 3 - Trang 308-321 - 2002
Flora Peyvandi, Stefano Duga, Sepideh Akhavan, Pier Mannuccio Mannucci
Summary. Deficiencies of coagulation factors (other than factor VIII and factor IX) that cause a bleeding disorder are inherited as autosomal recessive traits and are generally rare, with prevalences in the general population varying between 1 : 500 000 and 1 : 2 000 000. In the last few years, the number of patients with recessively transmitted coagulation deficien...... hiện toàn bộ Nanofiltration of plasma‐derived biopharmaceutical products Tập 9 Số 1 - Trang 24-37 - 2003
Thierry Burnouf, Mirjana Radosevich
Summary. This review presents the current status on the use and benefits of viral removal filtration systems – known as nanofiltration – in the manufacture of plasma‐derived coagulation factor concentrates and other biopharmaceutical products from human blood origin.Nanofiltration of plasma products has been implemented at a production scale in the e...... hiện toàn bộ Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention’s (CDC) Universal Data Collection (UDC) project Tập 15 Số 6 - Trang 1281-1290 - 2009
Roshni Kulkarni, J. Michael Soucie, Jeanne M. Lusher, Rodney Presley, Amy D. Shapiro, M. John Gill, Marilyn J. Manco‐Johnson, Marion A. Koerper, Prasad Mathew, Thomas C. Abshire, Donna DiMichele, Keith Hoots, Robert L. Janco, Diane J. Nugent, S. Geraghty, Bruce L. Evatt
Summary. Lack of detailed natural history and outcomes data for neonates and toddlers with haemophilia hampers the provision of optimal management of the disorder. We report an analysis of prospective data collected from 580 neonates and toddlers aged 0–2 years with haemophilia enrolled in the Universal Data Collection (UDC) surveillance project of the Centers for D...... hiện toàn bộ Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization Tập 10 Số 3 - Trang 218-231 - 2004
John Pasi, Paul W. Collins, David Keeling, Simon Brown, A. M. Cumming, Gerard Dolan, C. R. M. Hay, F. G. H. Hill, Michael Laffan, I. R. Peake
Summary. von Willebrand disease (VWD) is the commonest inherited bleeding disorder. The aim of therapy for VWD is to correct the two defects of haemostasis in this disorder, impaired primary haemostasis because of defective platelet adhesion and aggregation and impaired coagulation as a result of low levels of factor VIII. The objective of this guideline is to infor...... hiện toàn bộ